Kamada Ltd (KMDA) stock
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.07−0.09 (-1.10%)
Close on Nov 18, 2026Market cap $465.53MP/E –Yield –
Kamada operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Kamada's operating income for the twelve months ending Jun 30, 2026 was $27.83M, up 10.3% year over year. For fiscal 2025 it was $26.23M, up 30.8% from the year before. The highest annual figure on record is $26.23M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.23M | +30.8% |
| FY2024 | Dec 31, 2024 | $20.05M | +99.2% |
| FY2023 | Dec 31, 2023 | $10.06M | +122.1% |
| FY2022 | Dec 31, 2022 | $4.53M | – |
| FY2021 | Dec 31, 2021 | -$696.00K | -103.6% |
| FY2020 | Dec 31, 2020 | $19.24M | -15.6% |
| FY2019 | Dec 31, 2019 | $22.78M | +18.3% |
| FY2018 | Dec 31, 2018 | $19.26M | +158.7% |
| FY2017 | Dec 31, 2017 | $7.44M | – |
| FY2016 | Dec 31, 2016 | -$5.48M | – |
| FY2015 | Dec 31, 2015 | -$11.42M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.51M | +34.5% |
| Q1 FY2026 | Mar 31, 2026 | $6.95M | -10.8% |
| Q4 FY2025 | Dec 31, 2025 | $3.55M | -30.1% |
| Q3 FY2025 | Sep 30, 2025 | $7.82M | +47.6% |
| Q2 FY2025 | Jun 30, 2025 | $7.07M | +25.4% |
| Q1 FY2025 | Mar 31, 2025 | $7.80M | +93.0% |
| Q4 FY2024 | Dec 31, 2024 | $5.08M | +82.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.29M | +21.2% |
| Q2 FY2024 | Jun 30, 2024 | $5.64M | +114.4% |
| Q1 FY2024 | Mar 31, 2024 | $4.04M | +1397477.9% |
| Q4 FY2023 | Dec 31, 2023 | $2.78M | -38.7% |
| Q3 FY2023 | Sep 30, 2023 | $4.37M | +170391.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.63M | – |
| Q1 FY2023 | Mar 31, 2023 | $289 | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | $4.53M | – |
| Q3 FY2022 | Sep 30, 2022 | $2.56K | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.29M | -319.3% |
| Q1 FY2022 | Mar 31, 2022 | $246.00K | -90.7% |
| Q4 FY2021 | Dec 31, 2021 | -$3.30M | -142.5% |
| Q3 FY2021 | Sep 30, 2021 | -$804.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $1.05M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.65M | – |
| Q3 FY2020 | Sep 30, 2020 | $7.76M | – |
See a number that looks wrong?